The US Food and Drug Administration is facing pressure from Congress over how to handle the forthcoming flurry of applications for COVID-19 vaccines. A subcommittee of the House Oversight and Reform Committee is demanding that the agency commit to having its Vaccines and Related Biological Products Advisory Committee (VRBPAC) evaluate all the vaccine candidates FDA reviews.
The Subcommittee on Economic and Consumer Policy held a virtual briefing on 14 July to spotlight what it believes FDA...







